ABPI celebrates a month of major investment commitments into UK life sciences
Following two new major investments in UK life sciences in April - £300 million by AstraZeneca, and £150 million by Boehringer Ingelheim - the ABPI points to the real progress unlocked by the…
Read the full articleYou might also wanna read
ABPI response to Science and Technology Framework publication
ABPI·5d ago
ABPI responds to Bioscience and health technology sector statistics 2021
ABPI·5d ago
ABPI response to Board of Trade report on Life Sciences
ABPI·5d ago
Speech: ABPI Vice President Susan Rienow addresses Pharma Integrates conference
ABPI·5d ago
ABPI response to the Budget
ABPI·8d ago
UK life science industry sets out priorities for the Budget
ABPI·8d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.